COAT Landing page

The first therapy to reverse Alzheimer's at its structural root.

COAT™ is a non-invasive, at-home olfactory stimulation platform clinically proven to restore brain structure and cognitive function in early Alzheimer's disease and aMCI

+2.6%

Gray matter volume increase

92%

Patient adherence rate in trial

0

Serious adverse events recorded

+2.34

Units improvement (PACC Score)

The problem

A $1 trillion crisis with no real solution.

Over 5.7 million Americans live with early Alzheimer's disease or amnestic mild cognitive impairment. Despite recent anti-amyloid therapies like Lecanemab and Donanemab, a critical gap remains: clearing amyloid plaques does not stop neurodegeneration. Brain atrophy continues. Cognition declines.

Target amyloid but fail to restore brain structure or cognitive function

Require IV infusions, carry serious risks (ARIA, brain bleeds), and are inaccessible to most patients

Amyloid PET diagnostics are unreliable across ethnoracial groups, leaving underserved populations behind

No currently approved therapy restores cognitive function in early Alzheimer's disease.

Watch Video Here

Personalized odor pulses via nasal cannula

The COAT device delivers algorithmic odor pulses at home — no specialist visits, no infusions.

Engage the olfactory–hippocampal pathway

Stimulation drives synaptic strengthening and activates the brain's natural neuroplastic healing mechanisms.

MRI-confirmed brain volume growth

Over 12 weeks, patients show measurable hippocampal regrowth and meaningful cognitive improvement.

Why COAT wins

Three pillars that no existing therapy matches.

Non-invasive, at home

No infusions, no clinic visits, no specialist required. Patients complete their 18-minute daily session from their own home.

Neuroplasticity-based

Targets the root cause of structural brain decline — not just symptoms. COAT activates the brain's own healing mechanisms.

Ethnoracially inclusive

Proven effective across Black, Latinx, and all patient groups — addressing a critical gap left by amyloid-PET-dependent therapies.

Featured by the National Institutes of Health

Partnerships

A Better Solution Exists.

COAT™ is the first and only therapy that modifies Alzheimer's disease, restores brain structure, and improves cognitive function — safely, non-invasively, at home.